Nanocrystal-Loaded Micelles for the Enhanced In Vivo Circulation of Docetaxel

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Aug 7

PMID 34361634

Citations 7

Authors

Meng Cheng

Qiaoming Liu

Tiantian Gan

Yuanying Fang

Pengfei Yue

Yongbing Sun

Yi Jin

Jianfang Feng

Liangxing Tu

Affiliations

Soon will be listed here.

Abstract

Prolonging in vivo circulation has proved to be an efficient route for enhancing the therapeutic effect of rapidly metabolized drugs. In this study, we aimed to construct a nanocrystal-loaded micelles delivery system to enhance the blood circulation of docetaxel (DOC). We employed high-pressure homogenization to prepare docetaxel nanocrystals (DOC(Nc)), and then produced docetaxel nanocrystal-loaded micelles (DOC(Nc)@mPEG-PLA) by a thin-film hydration method. The particle sizes of optimized DOC(Nc), docetaxel micelles (DOC@mPEG-PLA), and DOC(Nc)@mPEG-PLA were 168.4, 36.3, and 72.5 nm, respectively. The crystallinity of docetaxel was decreased after transforming it into nanocrystals, and the crystalline state of docetaxel in micelles was amorphous. The constructed DOC(Nc)@mPEG-PLA showed good stability as its particle size showed no significant change in 7 days. Despite their rapid dissolution, docetaxel nanocrystals exhibited higher bioavailability. The micelles prolonged the retention time of docetaxel in the circulation system of rats, and DOC(Nc)@mPEG-PLA exhibited the highest retention time and bioavailability. These results reveal that constructing nanocrystal-loaded micelles may be a promising way to enhance the in vivo circulation and bioavailability of rapidly metabolized drugs such as docetaxel.

Citing Articles

Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport.

Tu L, Wang J, Sun Y, Wan Y AAPS PharmSciTech. 2024; 25(7):206.

PMID: 39237659 DOI: 10.1208/s12249-024-02898-4.

Substances of Natural Origin in Medicine: Plants vs. Cancer.

Gielecinska A, Kciuk M, Mujwar S, Celik I, Kolat D, Kaluzinska-Kolat Z Cells. 2023; 12(7).

PMID: 37048059 PMC: 10092955. DOI: 10.3390/cells12070986.

The Fabrication of Docetaxel-Containing Emulsion for Drug Release Kinetics and Lipid Peroxidation.

Wu Y, Wang M, Li Y, Xia H, Cheng Y, Liu C Pharmaceutics. 2022; 14(10).

PMID: 36297429 PMC: 9607308. DOI: 10.3390/pharmaceutics14101993.

A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH) and taxotere in ovarian cancer cells.

Taheri-Ledari R, Zolfaghari E, Zarei-Shokat S, KashtiAray A, Maleki A Commun Biol. 2022; 5(1):995.

PMID: 36130999 PMC: 9492675. DOI: 10.1038/s42003-022-03966-w.

Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties.

Ioele G, Chieffallo M, Occhiuzzi M, De Luca M, Garofalo A, Ragno G Molecules. 2022; 27(17).

PMID: 36080203 PMC: 9457551. DOI: 10.3390/molecules27175436.

References

Wei L, Ji Y, Gong W, Kang Z, Meng M, Zheng A . Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug Dev Ind Pharm. 2014; 41(8):1343-52. DOI: 10.3109/03639045.2014.950272. View

Wang Y, Ma Y, Ma Y, Du Y, Liu Z, Zhang D . Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery. J Nanosci Nanotechnol. 2012; 12(8):6176-84. DOI: 10.1166/jnn.2012.6436. View

Ruiz-Gaton L, Espuelas S, Huarte J, Larraneta E, Martin-Arbella N, Irache J . Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel. Int J Pharm. 2019; 571:118699. DOI: 10.1016/j.ijpharm.2019.118699. View

Hou J, Sun E, Sun C, Wang J, Yang L, Jia X . Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system. Int J Pharm. 2016; 512(1):186-193. DOI: 10.1016/j.ijpharm.2016.08.045. View

Cui W, Zhao H, Wang C, Chen Y, Luo C, Zhang S . Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy. Drug Deliv. 2019; 26(1):542-550. PMC: 6534241. DOI: 10.1080/10717544.2019.1616237. View

Tian C, Guo J, Wang G, Sun B, Na K, Zhang X . Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral Prodrugs. Adv Sci (Weinh). 2019; 6(24):1901810. PMC: 6918103. DOI: 10.1002/advs.201901810. View

Zhu C, Gong S, Ding J, Yu M, Ahmad E, Feng Y . Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex. Acta Pharm Sin B. 2019; 9(1):107-117. PMC: 6361729. DOI: 10.1016/j.apsb.2018.09.004. View

Tu L, Cheng M, Sun Y, Fang Y, Liu J, Liu W . Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: In vitro and in vivo evaluation. Int J Pharm. 2019; 573:118730. DOI: 10.1016/j.ijpharm.2019.118730. View

Hollis C, Weiss H, Leggas M, Evers B, Gemeinhart R, Li T . Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release. 2013; 172(1):12-21. PMC: 3886194. DOI: 10.1016/j.jconrel.2013.06.039. View

10.

Wang Y, Chen L, Tan L, Zhao Q, Luo F, Wei Y . PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials. 2014; 35(25):6972-85. DOI: 10.1016/j.biomaterials.2014.04.099. View

11.

Liu Q, Cheng M, Liang J, Jin Y, Feng J, Tu L . Enhancing Oral Bioavailability by Paclitaxel Polymeric Micelles: Role of Transmembrane Pathways in the Oral Absorption. J Biomed Nanotechnol. 2020; 16(7):1160-1168. DOI: 10.1166/jbn.2020.2956. View

12.

Liu H, Ma Y, Liu D, Fallon J, Liu F . The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study. J Biomed Nanotechnol. 2016; 12(1):147-53. DOI: 10.1166/jbn.2016.2127. View

13.

Liang H, Zou F, Liu Q, Wang B, Fu L, Liang X . Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy. Int J Pharm. 2021; 599:120418. DOI: 10.1016/j.ijpharm.2021.120418. View

14.

Hekmat A, Attar H, Seyf Kordi A, Iman M, Jaafari M . New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles. Molecules. 2016; 21(9). PMC: 6274371. DOI: 10.3390/molecules21091265. View

15.

Tam Y, Shin D, Chen K, Kwon G . Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)-paclitaxel prodrug: In Vivo conversion and antitumor efficacy. J Control Release. 2019; 298:186-193. PMC: 6466635. DOI: 10.1016/j.jconrel.2019.02.017. View

16.

Chen M, Li W, Zhang X, Dong Y, Hua Y, Zhang H . In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes. Int J Nanomedicine. 2017; 12:5487-5500. PMC: 5546766. DOI: 10.2147/IJN.S133816. View

17.

Wang X, Guo Y, Qiu L, Wang X, Li T, Han L . Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel. Carbohydr Polym. 2018; 206:121-131. DOI: 10.1016/j.carbpol.2018.10.096. View

18.

Tan L, Ma B, Zhao Q, Zhang L, Chen L, Peng J . Toxicity Evaluation and Anti-Tumor Study of Docetaxel Loaded mPEG-Polyester Micelles for Breast Cancer Therapy. J Biomed Nanotechnol. 2018; 13(4):393-408. View

19.

Mohammad I, Hu H, Yin L, He W . Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm. 2019; 562:187-202. DOI: 10.1016/j.ijpharm.2019.02.045. View

20.

Ye Y, Zhang X, Zhang T, Wang H, Wu B . Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug Dev Ind Pharm. 2014; 41(9):1416-24. DOI: 10.3109/03639045.2014.954585. View